Maravai LifeSciences (MRVI) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Maravai LifeSciences (MRVI) Tops Q1 EPS by 4c

Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance

May 10, 2021 4:05 PM EDT

SAN DIEGO, May 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2021. Highlights include:

Revenue increased 190.7% to $148.2 million for the first quarter;Updated 2021 revenue guidance of $680.0 million to $720.0 million, representing full year growth of 139.4% to 153.5%.

"As reported in our pre-announcement, Maravais strong momentum... More